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A threonine-12 to alanine mutant of E. coli asparaginase II (EC 3.5.1.1) has less than 0.01% of the activity of wild-type enzyme. Both tertiary 
and quaternary structure of the enzyme are essentially unaffected by the mutation; thus the activity loss seems to be the result of a direct impairment 
of catalytic function. As aspartate is still bound by the mutant enzyme, Thr-12 appears not be involved in substrate binding. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The asparaginases (EC 3.5.1.1) catalyze the 
hydrolysis of L-asparagine to L-aspartate and am- 
monia. Asparaginase isocnzyme II of Escherichia coli, 
an enzyme noted for its use as an anti-leukemia agent 
[l], has been extensively studied (for reviews see [2,3]). 
Kinetic evidence suggests that catalysis by asparaginase 
II involves a covalent intermediate, probably a ,% 
aspartyl enzyme [4,5]. However, the reactive group in 
the enzyme is still not known with certainty. Hand- 
Schumacher and his colleagues [6-B] showed that L-5- 
diazo-4-oxo-norvaline (DONV) covalently binds and in- 
activates E. coli asparaginase. This effect was at- 
tributed to modification of a serine residue in position 
120 of the recently corrected sequence [9]. However, the 
assignment was not unequivocal. At about the same 
time, Holcenberg et al. [IO] demonstrated that 
Acinetobacter glutaminase-asparaginase, which is 
highly homologous to E. co/i asparaginase II, is 
modified by DON (the norleucine analogue of DONV) 
at threonine-12. An 8 amino acid sequence encompass- 
ing this residue is conserved in most asparaginases ex- 
amined so far; this motif is, therefore, considered an 
asparaginase sequence “signature’. However, the role of 
threonine-12 in the asparaginases remained unclear. 
Here we describe the site-directed replacement of 
threonine-12 of E. co/i asparaginase II with alanine, 
and its effects on the structure and function of the en- 
zyme. 
2.1. Mutagenesis 
The construction of expression systems for E. co/i asparaginase II
is described in detail elsewhere [I 11. Before mutagenesis the 1.35 kB 
EcoRI/ffirrdllI fragment from expression vector pTWE1 (a 
derivative of pT7-7 carrying the wild type ansEt gene) was cloned into 
the multiple cloning site of M13mp19, using standard procedures 
[ 121. Oligonucleotide-mediated mutagenesis was performed accor- 
ding to the method of E : .iein and coworkers [I33 with a commercial 
kit (Amersham, Amershdm, UK). The codon for amino acid 12 was 
changed from ACC (Thr) to GCC (Ala) by introducing the synthetic 
18-mer primer .5’-ACCGGCGGCGCCATTGCC-3 ‘. The additional 
base eschange at position 9 of the primer replaces the triplet for 
City-1 I (GGG) with another glycine codon (GGC). This change in- 
troduced a new Narl restriction site (underlined) in order to facilitate 
identification of the mutant asparaginase gene. Recombinant phage 
plaques obtained in the mutagenesis experiment were propagated and 
screened for a new Nurl restriction site.The I.35 kb EcoRI/Hindlll 
fragment from such a a mutant phage was excised, isolated by agarose 
gel electrophoresis, and re-inserted into EcoRI/I-lindlll-cut vector 
pT7-7 for expression of the mutant enzyme. The resulting plasmid is 
called pTWE5. 
2.2. Expression and pur&ation 
Wild type and mutant asparaginases were expressed from pTWE1 
or pTWE5, respectively, with the asparaginase-free E. co/i strain 
CUl783 (111 as the host. Both enzymes were separated from cell 
pellets by osmotic shock and purified from the resulting supernatant 
fluid by ammonium sulfate fractionation and chromatofocusing as 
decribed [ll], 
2.3. Protein chemistry and activity assays 
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Protein concentrations were determined from UV spectra by 
assuming an absorption coefficient for asparaginase of A?&” = 0.74. 
Amino acid analyses were performed by reversed-phase HPLC of 
PTC-amino acids obtained by pre-column treatment of hydrolysates 
with phenyl isothiocyanate. Hydrolysis, derivative formation and 
analysis were carried out essentially as detailed in [14]. N-terminal se- 
quence analysis was performed by automated Edman degradation on 
an Applied Biosystems gas phase sequencer. The activity of wild type 
asparaginase was determined by direkt UC’ spectrophotometry at 225 
nm [2]. Another, more sensitive assay is based on the determination 
of hydroxylamine liberated from L-aspartic-&hydroxamate (151. The 
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latter method, which reliably detects asparaginase activities down to 
a few/rU, was used to assay solutions of mutant enzyme. Both types 
of assay were conducted in MES or MOPS buffers at pH 7.0 and 
2ST. 
2.4. Spectroscopy 
Fluorescence measurements were performed at 25°C on a Jasco 
FP-770 spectrofluorimeter. For all experiments enzyme solutions in 
50 mM MOPS/NaOH, 100 mM NaC!, pH 7.0, were employed. 
Fluorescence quenching by L-aspartic acid was studied by titrating I .5 
ml volumes of enzyme solution (0.5-3 mg protein/ml) with 10 /II 
volumes of 10 mM aspartic acid, pH 7.0 (excitation at 285 nm. emis- 
sion detected at 323 nm). NMW spectra were recorded at 500 MHz on 
a Bruker AMX-500 spectrometer. Sample preparation and ex- 
perimental details were similar to those described previously [16]. 
3. RESULTS AND DISCUSSION 
3.1 Structural properties of mu tan t T1.2 -+ A 
The T12+A mutant of asparaginase was purified by 
the same protocol as described for wild type enzyme, In 
both cases the yields of enzyme protein were com- 
parable (lo-15 mg/l of culture volume). Owing to the 
very low activity of the mutant, asparaginase- 
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The mutant enzyme was indistinguishable from wild 
type asparaginase with respect to a number of proper- 
ties. Its isoelectric point, as estimated by 
chromatofocusing was 4.8-4.9 (wild type = 4.8). Both 
enzyme species showed the same relative mobility dur- 
ing gel filtration on Sephacryl S-300 and comigrated in 
SDS gel electrophoresis. This suggests that the mutant, 
like wild-type enzyme, is a tetramer of 35 kDa subunits. 
The amino acid composition of the mutant and wild 
type asparaginase were identical within experimental er- 
ror, except for the values for Thr and Ala which 
displayed the expected shift towards a higher alanine 
content (data not shown). I-Iowever, with 34 threonine 
and 32 alanine residues per subunit of wild type en- 
zyme, the expected change is difficult to determine 
quantitatively, since Thr is partially destroyed during 
hydrolysis. Therefore, the presence of the T12+A 
change was confirmed by sequence analysis of the N- 
terminus of the mutant protein. The first 16 residues 
were as expected [9], including a glycine residue in posi- 
tion 11 and an alanine in position 12. 
[ASP] (mM) 
Fig. I. Fluorescence quenching by aspartate. (A) Fluorescence ernis- 
sion spectra of wild type asparaginase II ( -) and mutant T12-+A 
(-- -) at the same protein concentration. Excitation was at 285 nm, 
fluorescence isgiven in arbitrary units. (B) Percent changeof emission 
intensity at 323 nm upon titration with aspartate at pH 7.0. Again, the 
data are for wild type enzyme (O), and for mutant T1.2 +A (@). 
The present evidence further suggests that the gross 
conformation of the enzyme is not detectably affected 
by the mutation. So, for instance, the CD-spectra of 
both species were similar , as were their denaturation 
temperatures T,, measured by differential scanning 
calorimetry (B-Z. Chowdhry and K&I. Riihm, un- 
published data). 
3.2. Catalytic features 
specific activity of 150 U/mg under the same condi- 
tions. Although the E. coli host strain used, CU 1783, 
has been made asparaginase II-negative by genetic 
manipulations [ 111, we cannot entirely exclude that the 
observed residual activity is due to contamination with 
host enzyme activity. At present, detailed kinetic 
studies are in progress to clarify this point. 
The activity of the T!2-+A mutant is extremely low. In order to ascertain whether the loss of activity is 
With L-aspartic acid-,8-hydroxamate as the substrate, clue to impaired substrate binding, we examined the in- 
our preparation exhibited a specific acribity of iess than teraction of the mutant enzyme with L-aspartic acid. 
0.01 U/mg. In contrast, wild type asparaginase shows a Aspartate, a product of the hydrolysis reaction, is also 
56 
VOiUlll~ 255, number 1 
I, 11 I “a ’ I 11 ’ I, ” 1 IT 11 I, -7 I., 
9.0 8.5 9.0 39 70 6.5 Pm 
Fig. 2. Effect of aspartate on the ‘H-NMR spectrum of mutant TlZ+A. A 1.3 mM enzyme solution in unbuffered 350 mM NaCI, pH 5.0, was 
used. (a) (Upper trace) without aspartate; the marked signals correspond to 2 cit’rerent histidine residues (1,2) and a tyrosine residue, respectively 
(3,4). (b) (Lower trace) the same solution with 1 mol of aspartate added per mol subunit. Signals 1. 3 and 4 have broadened out. 
a competitive inhibi-ior as well as as a substrate of 
asparaginase-catalyzed oxygen-exchange [5]. Aspartic 
acid protonated at the,&carboxyl group binds at least as 
tightly to asparaginase II as L-asparagine. 
Two spectroscopic approaches were used. The first 
one is based on the observation by Homer [17] that 
aspartate binding slightly quenches the fluorescence of 
the single tryptophan residue of asparaginase 11. The 
fluorescence emission spectra of wild type asparaginase 
and the Thrl2-+Ala mutant are shown in Fig. IA. Ex- 
cept for a minor redshift of the spectrum of the mutant 
enzyme the curves are identical. Again, this suggests 
comparable protein conformations of both enzyme 
species. In contrast, the aspartic acid titration curves of 
wild type and mutant enzyme are different (Fig. 1B). 
Although the overall reduction of fluorescence upon 
aspartate binding was about the same in either case 
(3.5% at pH 7.0), the aspartate concentrations 
necessary to attain the maximal effect were 3-4-fold 
higher with the mutant enzyme. The shapes of both 
curves indicate that at least 2 different concentration- 
dependent effects are involved in fluorescence quen- 
ching, and a quantitative analysis is difficult with our 
present data. Nevertheless, it appears justified to con- 
clude that the mutant binds aspartic acid, although with 
somewhat reduced affinity. 
A second approach to study aspartate binding relied 
on changes in the aromatic region of the ‘H-NMR spec- 
trum previously observed with wild-type enzyme. Dur- 
ing progessive saturation with aspartate, one of the 
histidine C, signals as well as 2 additional peaks (at- 
tributed to a tyrosine residue) broaden and eventually 
disappear [ 161. Fig. 2 shows that exactly the same effect 
is exhibited by the Tl%*A mutant, indicating that 
aspartate is bound with close to normal affinity. 
From these findings we infer that Thr-12 of 
asparaginase II is not required for substrate binding, 
but is involved in catalysis. It is conceivable that 
Thr-12, like the active-site serine residues of the serine 
hydrolases, participstes in the covalent acyl enzyme in- 
termediate. Such a role of a threonine residue would be 
rather uncommon. On the other hand, a hydrogen bond 
formed by the hydroxyl group of Thr-12 might be re- 
quired for transition-state stabilization or some subse- 
quent step in the catalytic cycle. Experiments to 
elucidate the role of Thr-12 are under way in our 
laboratory. 
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